المؤلفون: Greenough A., Heath P.T., Kennea N., Bedford Russell A., Cailes B., Kortsalioudaki C., Buttery J., Pattnayak S., Matthes J.

مصطلحات الفهرس: Pseudomonas, Serratia, Staphylococcus aureus, Streptococcus, Streptococcus agalactiae, treatment outcome, Escherichia coli, Enterococcus, Enterobacter, birth weight, antibiotic sensitivity, newborn sepsis/dr [Drug Resistance], nonhuman, practice guideline, priority journal, vancomycin/dt [Drug Therapy], antibiotic resistance, Acinetobacter, human, infectious agent, Klebsiella, Micrococcus, newborn, newborn sepsis/dt [Drug Therapy], article, United Kingdom, amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], antiinfective agent/dt [Drug Therapy], cefotaxime/cb [Drug Combination], cefotaxime/dt [Drug Therapy], clavulanic acid/cb [Drug Combination], clavulanic acid/dt [Drug Therapy], flucloxacillin/cb [Drug Combination], flucloxacillin/dt [Drug Therapy], gentamicin/cb [Drug Combination], gentamicin/dt [Drug Therapy], penicillin G/cb [Drug Combination], penicillin G/dt [Drug Therapy], piperacillin plus tazobactam/cb [Drug Combination], piperacillin plus tazobactam/dt [Drug Therapy], vancomycin/cb [Drug Combination], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38596
Archives of Disease in Childhood: Fetal and Neonatal Edition
Click here for full text options
LibKey Link

المؤلفون: Greenough A., Heath P.T., Kennea N., Bedford Russell A., Cailes B., Kortsalioudaki C., Buttery J., Pattnayak S., Matthes J.

مصطلحات الفهرس: Pseudomonas, Serratia, Staphylococcus aureus, Streptococcus, Streptococcus agalactiae, treatment outcome, Escherichia coli, Enterococcus, Enterobacter, birth weight, antibiotic sensitivity, newborn sepsis/dr [Drug Resistance], nonhuman, practice guideline, priority journal, vancomycin/dt [Drug Therapy], antibiotic resistance, Acinetobacter, human, infectious agent, Klebsiella, Micrococcus, newborn, newborn sepsis/dt [Drug Therapy], article, United Kingdom, amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], antiinfective agent/dt [Drug Therapy], cefotaxime/cb [Drug Combination], cefotaxime/dt [Drug Therapy], clavulanic acid/cb [Drug Combination], clavulanic acid/dt [Drug Therapy], flucloxacillin/cb [Drug Combination], flucloxacillin/dt [Drug Therapy], gentamicin/cb [Drug Combination], gentamicin/dt [Drug Therapy], penicillin G/cb [Drug Combination], penicillin G/dt [Drug Therapy], piperacillin plus tazobactam/cb [Drug Combination], piperacillin plus tazobactam/dt [Drug Therapy], vancomycin/cb [Drug Combination], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38596
Archives of Disease in Childhood: Fetal and Neonatal Edition
Click here for full text options
LibKey Link

المؤلفون: Abbott M., Grayson M.L., Kerr P.G., Grabsch E.A., Johnson P.D.R., Olden D., Aberline M., Li H.Y., Hogg G.

مصطلحات الفهرس: ampicillin/cb [Drug Combination], ampicillin/dt [Drug Therapy], antibiotic agent/cb [Drug Combination], antibiotic agent/dt [Drug Therapy], bacitracin/dt [Drug Therapy], cephalosporin derivative, gentamicin, vancomycin, peritoneal dialysis, antibiotic resistance, article, bacterial colonization, bacterial gene, bacterial infection/co [Complication], bacterial infection/dr [Drug Resistance], bacterial infection/dt [Drug Therapy], bacterial infection/ep [Epidemiology], bacterial infection/et [Etiology], drug use, Enterococcus, Enterococcus faecalis, Enterococcus faecium, feces analysis, hemodialysis, high risk patient, human, major clinical study, polymerase chain reaction, pulsed field gel electrophoresis, screening, amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26622
Medical Journal of Australia
Click here for full text options
LibKey Link

المؤلفون: Turnidge J.D., Midolo P.D., Lambert J.R.

مصطلحات الفهرس: omeprazole/cb [Drug Combination], omeprazole/it [Drug Interaction], proton pump inhibitor/it [Drug Interaction], antibiotic agent/it [Drug Interaction], article, bactericidal activity, drug potentiation, Helicobacter pylori, nonhuman, amoxicillin/cb [Drug Combination], amoxicillin/it [Drug Interaction], beta lactam antibiotic/cb [Drug Combination], beta lactam antibiotic/it [Drug Interaction], erythromycin/cb [Drug Combination], erythromycin/it [Drug Interaction], lansoprazole/cb [Drug Combination], lansoprazole/it [Drug Interaction], macrolide/cb [Drug Combination], macrolide/it [Drug Interaction], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33929
Click here for full text options
LibKey Link

المؤلفون: Turnidge J., Grayson M.L.

مصطلحات الفهرس: drug potency, drug protein binding, gastrointestinal symptom/si [Side Effect], Gram negative bacterium, hospital infection, human, interstitial nephritis/si [Side Effect], intravenous drug administration, lung infection/dt [Drug Therapy], nephrotoxicity/si [Side Effect], oral drug administration, osteomyelitis/dt [Drug Therapy], penicillin resistance, pharmacokinetics, review, sepsis/dt [Drug Therapy], skin infection/dt [Drug Therapy], Staphylococcus aureus, Staphylococcus infection/dt [Drug Therapy], toxic shock syndrome/dt [Drug Therapy], aminoglycoside antibiotic agent/dt [Drug Therapy], amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], ampicillin/cb [Drug Combination], ampicillin/dt [Drug Therapy], azithromycin/dt [Drug Therapy], beta lactam/cb [Drug Combination], beta lactam/dt [Drug Therapy], beta lactamase/ec [Endogenous Compound], cefaclor/dt [Drug Therapy], cefadroxil/dt [Drug Therapy], cefalexin/dt [Drug Therapy], cefaloridine/dt [Drug Therapy], cefalotin/dt [Drug Therapy], cefamandole/dt [Drug Therapy], cefapirin/dt [Drug Therapy], cefazolin/dt [Drug Therapy], cefradine/dt [Drug Therapy], cefuroxime/dt [Drug Therapy], cephalosporin/dt [Drug Therapy], chloramphenicol/dt [Drug Therapy], ciprofloxacin/dt [Drug Therapy], clarithromycin/dt [Drug Therapy], clavulanic acid/cb [Drug Combination], clavulanic acid/dt [Drug Therapy], clindamycin/dt [Drug Therapy], cloxacillin/dt [Drug Therapy], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], dicloxacillin/dt [Drug Therapy], enoxacin/dt [Drug Therapy], enzyme inhibitor, erythromycin/dt [Drug Therapy], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/dt [Drug Therapy], fosfomycin/dt [Drug Therapy], fusidic acid/dt [Drug Therapy], imipenem/dt [Drug Therapy], lincomycin/dt [Drug Therapy], meticillin/ae [Adverse Drug Reaction], meticillin/dt [Drug Therapy], minocycline/dt [Drug Therapy], nafcillin/dt [Drug Therapy], ofloxacin/dt [Drug Therapy], oxacillin/dt [Drug Therapy], pefloxacin/dt [Drug Therapy], penicillin G/dt [Drug Therapy], penicillinase/cb [Drug Combination], penicillinase/dt [Drug Therapy], piperacillin/cb [Drug Combination], piperacillin/dt [Drug Therapy], quinoline derived antiinfective agent/dt [Drug Therapy], rifampicin/dt [Drug Therapy], roxithromycin/dt [Drug Therapy], sulbactam/cb [Drug Combination], sulbactam/dt [Drug Therapy], sulfamethoxazole/cb [Drug Combination], sulfamethoxazole/dt [Drug Therapy], tazobactam/cb [Drug Combination], tazobactam/dt [Drug Therapy], teicoplanin/dt [Drug Therapy], temafloxacin/dt [Drug Therapy], tetracycline/dt [Drug Therapy], ticarcillin/cb [Drug Combination], ticarcillin/dt [Drug Therapy], trimethoprim/cb [Drug Combination], trimethoprim/dt [Drug Therapy], vancomycin/dt [Drug Therapy], priority journal, abscess/dt [Drug Therapy], allergy/si [Side Effect], anaphylaxis/si [Side Effect], antibiotic resistance, antibiotic therapy, antimicrobial therapy, aplastic anemia/si [Side Effect], bacteremia/et [Etiology], bacterial endocarditis/dt [Drug Therapy], bacterial meningitis/dt [Drug Therapy], cholestasis/si [Side Effect], coagulase negative Staphylococcus, drug efficacy, drug mixture, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34435
Click here for full text options
LibKey Link

المؤلفون: Lambert J.R., Dev A.T.

مصطلحات الفهرس: diarrhea/si [Side Effect], disease association, drug choice, drug efficacy, drug potentiation, drug tolerability, dyspepsia/dt [Drug Therapy], dyspepsia/si [Side Effect], eradication therapy, gastritis/co [Complication], gastritis/et [Etiology], gastroduodenal ulcer/co [Complication], gastroduodenal ulcer/dt [Drug Therapy], gastroduodenal ulcer/et [Etiology], gastroduodenal ulcer/si [Side Effect], Gram negative infection/di [Diagnosis], Gram negative infection/dt [Drug Therapy], Gram negative infection/ep [Epidemiology], Gram negative infection/et [Etiology], Helicobacter pylori, histology, human, mucosa associated lymphoid tissue lymphoma/co [Complication], mucosa associated lymphoid tissue lymphoma/et [Etiology], nausea/si [Side Effect], pathogenesis, patient compliance, pseudomembranous colitis/si [Side Effect], review, serodiagnosis, side effect, stomach adenocarcinoma/co [Complication], stomach adenocarcinoma/et [Etiology], taste disorder/si [Side Effect], amoxicillin/cb [Drug Combination], amoxicillin/do [Drug Dose], amoxicillin/dt [Drug Therapy], bismuth/ae [Adverse Drug Reaction], bismuth/do [Drug Dose], bismuth/it [Drug Interaction], metronidazole/ae [Adverse Drug Reaction], metronidazole/cb [Drug Combination], metronidazole/do [Drug Dose], metronidazole/dt [Drug Therapy], nonsteroid antiinflammatory agent/ae [Adverse Drug Reaction], nonsteroid antiinflammatory agent/dt [Drug Therapy], omeprazole/cb [Drug Combination], omeprazole/do [Drug Dose], omeprazole/it [Drug Interaction], omeprazole/dt [Drug Therapy], pantoprazole/cb [Drug Combination], pantoprazole/do [Drug Dose], pantoprazole/dt [Drug Therapy], proton pump inhibitor/cb [Drug Combination], proton pump inhibitor/do [Drug Dose], proton pump inhibitor/it [Drug Interaction], proton pump inhibitor/dt [Drug Therapy], ranitidine bismuth citrate/do [Drug Dose], ranitidine bismuth citrate/dt [Drug Therapy], tetracycline/do [Drug Dose], tetracycline/dt [Drug Therapy], unclassified drug, urea/ec [Endogenous Compound], helidac/do [Drug Dose], helidac/dt [Drug Therapy], endoscope, bismuth/dt [Drug Therapy], bismuth citrate/do [Drug Dose], bismuth citrate/dt [Drug Therapy], clarithromycin/ae [Adverse Drug Reaction], clarithromycin/cb [Drug Combination], clarithromycin/dt [Drug Therapy], histamine H2 receptor antagonist/dt [Drug Therapy], lansoprazole/cb [Drug Combination], lansoprazole/dt [Drug Therapy], antibiotic resistance, antibiotic therapy, breath analysis, carcinogenesis/co [Complication], clinical feature, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28480
Medical Journal of Australia
Click here for full text options
LibKey Link

المؤلفون: Hawley C.M., Johnson D.W., Bannister K.M., Wiggins K.J., Rosman J.B., Brown F.G., Barraclough K., McDonald S.P.

مصطلحات الفهرس: vancomycin/dt [Drug Therapy], vancomycin/ip [Intraperitoneal Drug Administration], peritoneal dialysis, teicoplanin/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], carbapenem/dt [Drug Therapy], cefalotin/dt [Drug Therapy], cefazolin/dt [Drug Therapy], ceftazidime/dt [Drug Therapy], ceftriaxone/dt [Drug Therapy], cephalosporin derivative/dt [Drug Therapy], ciprofloxacin/dt [Drug Therapy], cloxacillin/dt [Drug Therapy], cotrimoxazole/dt [Drug Therapy], dicloxacillin/dt [Drug Therapy], erythromycin/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], gentamicin/cb [Drug Combination], gentamicin/dt [Drug Therapy], metronidazole/dt [Drug Therapy], rifampicin/dt [Drug Therapy], ticarcillin/dt [Drug Therapy], vancomycin/cb [Drug Combination], adult, aged, article, Australia, body mass, catheter removal, controlled study, Corynebacterium infection/dt [Drug Therapy], Corynebacterium infection/th [Therapy], female, hemodialysis patient, hospitalization, human, incidence, major clinical study, male, peritonitis/dt [Drug Therapy], peritonitis/th [Therapy], priority journal, relapse, treatment outcome, aminoglycoside/dt [Drug Therapy], amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], ampicillin/cb [Drug Combination], ampicillin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31237
Click here for full text options
LibKey Link

المؤلفون: Turnidge J.

مصطلحات الفهرس: cefalexin/dt [Drug Therapy], chloramphenicol/dt [Drug Therapy], ciprofloxacin/dt [Drug Therapy], clavulanic acid/dt [Drug Therapy], clindamycin/dt [Drug Therapy], cloxacillin/dt [Drug Therapy], erythromycin/dt [Drug Therapy], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/dt [Drug Therapy], fusidic acid/dt [Drug Therapy], rifampicin/dt [Drug Therapy], roxithromycin/dt [Drug Therapy], tetracycline derivative/dt [Drug Therapy], bacterial infection/dt [Drug Therapy], editorial, hepatitis/si [Side Effect], human, skin infection, soft tissue infection, Staphylococcus aureus, Streptococcus pyogenes, amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], cefaclor/dt [Drug Therapy], Editorial

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34222
Click here for full text options
LibKey Link

المؤلفون: Midolo P.D., Sievert W.

مصطلحات الفهرس: duodenum ulcer/et [Etiology], Helicobacter pylori, human, letter, male, minimum inhibitory concentration, recurrent infection, treatment failure, amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], antibiotic agent/cb [Drug Combination], antibiotic agent/dt [Drug Therapy], unclassified drug, helidac/cb [Drug Combination], helidac/dt [Drug Therapy], hp 7/cb [Drug Combination], hp 7/dt [Drug Therapy], nonhuman, adult, antibiotic resistance, antibiotic sensitivity, Australia, bacterial infection/dr [Drug Resistance], bacterial infection/dt [Drug Therapy], bacterial infection/et [Etiology], bacterium culture, bacterium isolate, biopsy, case report, drug surveillance program, duodenum ulcer/dr [Drug Resistance], duodenum ulcer/dt [Drug Therapy], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27468
Medical Journal of Australia
LibKey Link

المؤلفون: Abbott M., Grayson M.L., Kerr P.G., Grabsch E.A., Johnson P.D.R., Olden D., Aberline M., Li H.Y., Hogg G.

مصطلحات الفهرس: ampicillin/cb [Drug Combination], ampicillin/dt [Drug Therapy], antibiotic agent/cb [Drug Combination], antibiotic agent/dt [Drug Therapy], bacitracin/dt [Drug Therapy], cephalosporin derivative, gentamicin, vancomycin, peritoneal dialysis, antibiotic resistance, article, bacterial colonization, bacterial gene, bacterial infection/co [Complication], bacterial infection/dr [Drug Resistance], bacterial infection/dt [Drug Therapy], bacterial infection/ep [Epidemiology], bacterial infection/et [Etiology], drug use, Enterococcus, Enterococcus faecalis, Enterococcus faecium, feces analysis, hemodialysis, high risk patient, human, major clinical study, polymerase chain reaction, pulsed field gel electrophoresis, screening, amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/26622
Medical Journal of Australia
LibKey Link

المؤلفون: Midolo P.D., Ward P., Rerksuppaphol S., Hardikar W.

مصطلحات الفهرس: gastroscopy, gender, Helicobacter pylori, human, incidence, male, minimum inhibitory concentration, nonhuman, priority journal, prospective study, statistical significance, strain identification, symptomatology, treatment outcome, amoxicillin/cb [Drug Combination], amoxicillin/cm [Drug Comparison], amoxicillin/dt [Drug Therapy], amoxicillin/pd [Pharmacology], antiinfective agent/cm [Drug Comparison], bismuth/cb [Drug Combination], bismuth/dt [Drug Therapy], clarithromycin/cb [Drug Combination], clarithromycin/cm [Drug Comparison], clarithromycin/dt [Drug Therapy], clarithromycin/pd [Pharmacology], metronidazole/cb [Drug Combination], metronidazole/cm [Drug Comparison], metronidazole/dt [Drug Therapy], metronidazole/pd [Pharmacology], omeprazole/cb [Drug Combination], omeprazole/dt [Drug Therapy], tetracycline/cm [Drug Comparison], e test, sensitivity analysis, adolescent, age, antibiotic resistance, antibiotic sensitivity, article, bacterium isolation, child, childhood disease/dr [Drug Resistance], childhood disease/dt [Drug Therapy], clinical article, clinical feature, demography, eradication therapy, ethnology, Europe, female, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32665
LibKey Link

المؤلفون: Turnidge J.D., Midolo P.D., Lambert J.R.

مصطلحات الفهرس: omeprazole/cb [Drug Combination], omeprazole/it [Drug Interaction], proton pump inhibitor/it [Drug Interaction], antibiotic agent/it [Drug Interaction], article, bactericidal activity, drug potentiation, Helicobacter pylori, nonhuman, amoxicillin/cb [Drug Combination], amoxicillin/it [Drug Interaction], beta lactam antibiotic/cb [Drug Combination], beta lactam antibiotic/it [Drug Interaction], erythromycin/cb [Drug Combination], erythromycin/it [Drug Interaction], lansoprazole/cb [Drug Combination], lansoprazole/it [Drug Interaction], macrolide/cb [Drug Combination], macrolide/it [Drug Interaction], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33929
LibKey Link

المؤلفون: Turnidge J., Grayson M.L.

مصطلحات الفهرس: drug potency, drug protein binding, gastrointestinal symptom/si [Side Effect], Gram negative bacterium, hospital infection, human, interstitial nephritis/si [Side Effect], intravenous drug administration, lung infection/dt [Drug Therapy], nephrotoxicity/si [Side Effect], oral drug administration, osteomyelitis/dt [Drug Therapy], penicillin resistance, pharmacokinetics, review, sepsis/dt [Drug Therapy], skin infection/dt [Drug Therapy], Staphylococcus aureus, Staphylococcus infection/dt [Drug Therapy], toxic shock syndrome/dt [Drug Therapy], aminoglycoside antibiotic agent/dt [Drug Therapy], amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], ampicillin/cb [Drug Combination], ampicillin/dt [Drug Therapy], azithromycin/dt [Drug Therapy], beta lactam/cb [Drug Combination], beta lactam/dt [Drug Therapy], beta lactamase/ec [Endogenous Compound], cefaclor/dt [Drug Therapy], cefadroxil/dt [Drug Therapy], cefalexin/dt [Drug Therapy], cefaloridine/dt [Drug Therapy], cefalotin/dt [Drug Therapy], cefamandole/dt [Drug Therapy], cefapirin/dt [Drug Therapy], cefazolin/dt [Drug Therapy], cefradine/dt [Drug Therapy], cefuroxime/dt [Drug Therapy], cephalosporin/dt [Drug Therapy], chloramphenicol/dt [Drug Therapy], ciprofloxacin/dt [Drug Therapy], clarithromycin/dt [Drug Therapy], clavulanic acid/cb [Drug Combination], clavulanic acid/dt [Drug Therapy], clindamycin/dt [Drug Therapy], cloxacillin/dt [Drug Therapy], cotrimoxazole/cb [Drug Combination], cotrimoxazole/dt [Drug Therapy], dicloxacillin/dt [Drug Therapy], enoxacin/dt [Drug Therapy], enzyme inhibitor, erythromycin/dt [Drug Therapy], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/dt [Drug Therapy], fosfomycin/dt [Drug Therapy], fusidic acid/dt [Drug Therapy], imipenem/dt [Drug Therapy], lincomycin/dt [Drug Therapy], meticillin/ae [Adverse Drug Reaction], meticillin/dt [Drug Therapy], minocycline/dt [Drug Therapy], nafcillin/dt [Drug Therapy], ofloxacin/dt [Drug Therapy], oxacillin/dt [Drug Therapy], pefloxacin/dt [Drug Therapy], penicillin G/dt [Drug Therapy], penicillinase/cb [Drug Combination], penicillinase/dt [Drug Therapy], piperacillin/cb [Drug Combination], piperacillin/dt [Drug Therapy], quinoline derived antiinfective agent/dt [Drug Therapy], rifampicin/dt [Drug Therapy], roxithromycin/dt [Drug Therapy], sulbactam/cb [Drug Combination], sulbactam/dt [Drug Therapy], sulfamethoxazole/cb [Drug Combination], sulfamethoxazole/dt [Drug Therapy], tazobactam/cb [Drug Combination], tazobactam/dt [Drug Therapy], teicoplanin/dt [Drug Therapy], temafloxacin/dt [Drug Therapy], tetracycline/dt [Drug Therapy], ticarcillin/cb [Drug Combination], ticarcillin/dt [Drug Therapy], trimethoprim/cb [Drug Combination], trimethoprim/dt [Drug Therapy], vancomycin/dt [Drug Therapy], priority journal, abscess/dt [Drug Therapy], allergy/si [Side Effect], anaphylaxis/si [Side Effect], antibiotic resistance, antibiotic therapy, antimicrobial therapy, aplastic anemia/si [Side Effect], bacteremia/et [Etiology], bacterial endocarditis/dt [Drug Therapy], bacterial meningitis/dt [Drug Therapy], cholestasis/si [Side Effect], coagulase negative Staphylococcus, drug efficacy, drug mixture, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34435
LibKey Link

المؤلفون: Lambert J.R., Dev A.T.

مصطلحات الفهرس: diarrhea/si [Side Effect], disease association, drug choice, drug efficacy, drug potentiation, drug tolerability, dyspepsia/dt [Drug Therapy], dyspepsia/si [Side Effect], eradication therapy, gastritis/co [Complication], gastritis/et [Etiology], gastroduodenal ulcer/co [Complication], gastroduodenal ulcer/dt [Drug Therapy], gastroduodenal ulcer/et [Etiology], gastroduodenal ulcer/si [Side Effect], Gram negative infection/di [Diagnosis], Gram negative infection/dt [Drug Therapy], Gram negative infection/ep [Epidemiology], Gram negative infection/et [Etiology], Helicobacter pylori, histology, human, mucosa associated lymphoid tissue lymphoma/co [Complication], mucosa associated lymphoid tissue lymphoma/et [Etiology], nausea/si [Side Effect], pathogenesis, patient compliance, pseudomembranous colitis/si [Side Effect], review, serodiagnosis, side effect, stomach adenocarcinoma/co [Complication], stomach adenocarcinoma/et [Etiology], taste disorder/si [Side Effect], amoxicillin/cb [Drug Combination], amoxicillin/do [Drug Dose], amoxicillin/dt [Drug Therapy], bismuth/ae [Adverse Drug Reaction], bismuth/do [Drug Dose], bismuth/it [Drug Interaction], metronidazole/ae [Adverse Drug Reaction], metronidazole/cb [Drug Combination], metronidazole/do [Drug Dose], metronidazole/dt [Drug Therapy], nonsteroid antiinflammatory agent/ae [Adverse Drug Reaction], nonsteroid antiinflammatory agent/dt [Drug Therapy], omeprazole/cb [Drug Combination], omeprazole/do [Drug Dose], omeprazole/it [Drug Interaction], omeprazole/dt [Drug Therapy], pantoprazole/cb [Drug Combination], pantoprazole/do [Drug Dose], pantoprazole/dt [Drug Therapy], proton pump inhibitor/cb [Drug Combination], proton pump inhibitor/do [Drug Dose], proton pump inhibitor/it [Drug Interaction], proton pump inhibitor/dt [Drug Therapy], ranitidine bismuth citrate/do [Drug Dose], ranitidine bismuth citrate/dt [Drug Therapy], tetracycline/do [Drug Dose], tetracycline/dt [Drug Therapy], unclassified drug, urea/ec [Endogenous Compound], helidac/do [Drug Dose], helidac/dt [Drug Therapy], endoscope, bismuth/dt [Drug Therapy], bismuth citrate/do [Drug Dose], bismuth citrate/dt [Drug Therapy], clarithromycin/ae [Adverse Drug Reaction], clarithromycin/cb [Drug Combination], clarithromycin/dt [Drug Therapy], histamine H2 receptor antagonist/dt [Drug Therapy], lansoprazole/cb [Drug Combination], lansoprazole/dt [Drug Therapy], antibiotic resistance, antibiotic therapy, breath analysis, carcinogenesis/co [Complication], clinical feature, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28480
Medical Journal of Australia
LibKey Link

المؤلفون: Hawley C.M., Johnson D.W., Bannister K.M., Wiggins K.J., Rosman J.B., Brown F.G., Barraclough K., McDonald S.P.

مصطلحات الفهرس: vancomycin/dt [Drug Therapy], vancomycin/ip [Intraperitoneal Drug Administration], peritoneal dialysis, teicoplanin/dt [Drug Therapy], antifungal agent/dt [Drug Therapy], carbapenem/dt [Drug Therapy], cefalotin/dt [Drug Therapy], cefazolin/dt [Drug Therapy], ceftazidime/dt [Drug Therapy], ceftriaxone/dt [Drug Therapy], cephalosporin derivative/dt [Drug Therapy], ciprofloxacin/dt [Drug Therapy], cloxacillin/dt [Drug Therapy], cotrimoxazole/dt [Drug Therapy], dicloxacillin/dt [Drug Therapy], erythromycin/dt [Drug Therapy], flucloxacillin/dt [Drug Therapy], gentamicin/cb [Drug Combination], gentamicin/dt [Drug Therapy], metronidazole/dt [Drug Therapy], rifampicin/dt [Drug Therapy], ticarcillin/dt [Drug Therapy], vancomycin/cb [Drug Combination], adult, aged, article, Australia, body mass, catheter removal, controlled study, Corynebacterium infection/dt [Drug Therapy], Corynebacterium infection/th [Therapy], female, hemodialysis patient, hospitalization, human, incidence, major clinical study, male, peritonitis/dt [Drug Therapy], peritonitis/th [Therapy], priority journal, relapse, treatment outcome, aminoglycoside/dt [Drug Therapy], amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], ampicillin/cb [Drug Combination], ampicillin/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31237
LibKey Link

المؤلفون: Turnidge J.

مصطلحات الفهرس: cefalexin/dt [Drug Therapy], chloramphenicol/dt [Drug Therapy], ciprofloxacin/dt [Drug Therapy], clavulanic acid/dt [Drug Therapy], clindamycin/dt [Drug Therapy], cloxacillin/dt [Drug Therapy], erythromycin/dt [Drug Therapy], flucloxacillin/ae [Adverse Drug Reaction], flucloxacillin/dt [Drug Therapy], fusidic acid/dt [Drug Therapy], rifampicin/dt [Drug Therapy], roxithromycin/dt [Drug Therapy], tetracycline derivative/dt [Drug Therapy], bacterial infection/dt [Drug Therapy], editorial, hepatitis/si [Side Effect], human, skin infection, soft tissue infection, Staphylococcus aureus, Streptococcus pyogenes, amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], cefaclor/dt [Drug Therapy], Editorial

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/34222
LibKey Link

المؤلفون: Birch C., Druce J., Bardin P., Hart D., Irving L., Ryan N., Charles P.G.P., Whitby M., Fuller A.J., Stirling R., Wright A.A., Korman T.M., Holmes P.W., Christiansen K.J., Waterer G.W., Pierce R.J.P., Mayall B.C., Armstrong J.G., Catton M.G., Nimmo G.R., Johnson B., Hooy M., Grayson M.L., Grayson L., Johnson P., Munckhof W., Looke D., Garske L., Playford G., Spelman D., Kotsimbos T., Holmes P., Heath C.

مصطلحات الفهرس: ceftriaxone/dt [Drug Therapy], penicillin G/dt [Drug Therapy], roxithromycin/cb [Drug Combination], roxithromycin/dt [Drug Therapy], community acquired pneumonia/dt [Drug Therapy], community acquired pneumonia/ep [Epidemiology], community acquired pneumonia/et [Etiology], controlled clinical trial, controlled study, female, Haemophilus influenzae, human, influenza, Influenza virus, Legionella, major clinical study, male, Moraxella catarrhalis, mortality, multicenter study, Mycoplasma pneumoniae, outcome assessment, Parainfluenza virus, Picornavirus, Pneumonia Severity Index, polymerase chain reaction, practice guideline, priority journal, prospective study, Pseudomonas aeruginosa, Respiratory syncytial pneumovirus, respiratory virus, serodiagnosis, Staphylococcus aureus, Streptococcus pneumoniae, treatment failure, virus infection, amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], cefotaxime/cb [Drug Combination], cefotaxime/dt [Drug Therapy], ceftriaxone/cb [Drug Combination], cefuroxime/cb [Drug Combination], cefuroxime/dt [Drug Therapy], clarithromycin/cb [Drug Combination], clarithromycin/dt [Drug Therapy], doxycycline/cb [Drug Combination], doxycycline/dt [Drug Therapy], erythromycin/cb [Drug Combination], erythromycin/dt [Drug Therapy], hypertensive factor/dt [Drug Therapy], macrolide/cb [Drug Combination], macrolide/dt [Drug Therapy], moxifloxacin/cb [Drug Combination], moxifloxacin/dt [Drug Therapy], penicillin G/cb [Drug Combination], Adenovirus, adult, antibiotic resistance, article, artificial ventilation, Australia, bacterial infection, Chlamydophila, clinical assessment, clinical trial, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31549
Clinical Infectious Diseases
Click here for full text options
LibKey Link

المؤلفون: Birch C., Druce J., Bardin P., Hart D., Irving L., Ryan N., Charles P.G.P., Whitby M., Fuller A.J., Stirling R., Wright A.A., Korman T.M., Holmes P.W., Christiansen K.J., Waterer G.W., Pierce R.J.P., Mayall B.C., Armstrong J.G., Catton M.G., Nimmo G.R., Johnson B., Hooy M., Grayson M.L., Grayson L., Johnson P., Munckhof W., Looke D., Garske L., Playford G., Spelman D., Kotsimbos T., Holmes P., Heath C.

مصطلحات الفهرس: ceftriaxone/dt [Drug Therapy], penicillin G/dt [Drug Therapy], roxithromycin/cb [Drug Combination], roxithromycin/dt [Drug Therapy], community acquired pneumonia/dt [Drug Therapy], community acquired pneumonia/ep [Epidemiology], community acquired pneumonia/et [Etiology], controlled clinical trial, controlled study, female, Haemophilus influenzae, human, influenza, Influenza virus, Legionella, major clinical study, male, Moraxella catarrhalis, mortality, multicenter study, Mycoplasma pneumoniae, outcome assessment, Parainfluenza virus, Picornavirus, Pneumonia Severity Index, polymerase chain reaction, practice guideline, priority journal, prospective study, Pseudomonas aeruginosa, Respiratory syncytial pneumovirus, respiratory virus, serodiagnosis, Staphylococcus aureus, Streptococcus pneumoniae, treatment failure, virus infection, amoxicillin/cb [Drug Combination], amoxicillin/dt [Drug Therapy], azithromycin/cb [Drug Combination], azithromycin/dt [Drug Therapy], cefotaxime/cb [Drug Combination], cefotaxime/dt [Drug Therapy], ceftriaxone/cb [Drug Combination], cefuroxime/cb [Drug Combination], cefuroxime/dt [Drug Therapy], clarithromycin/cb [Drug Combination], clarithromycin/dt [Drug Therapy], doxycycline/cb [Drug Combination], doxycycline/dt [Drug Therapy], erythromycin/cb [Drug Combination], erythromycin/dt [Drug Therapy], hypertensive factor/dt [Drug Therapy], macrolide/cb [Drug Combination], macrolide/dt [Drug Therapy], moxifloxacin/cb [Drug Combination], moxifloxacin/dt [Drug Therapy], penicillin G/cb [Drug Combination], Adenovirus, adult, antibiotic resistance, article, artificial ventilation, Australia, bacterial infection, Chlamydophila, clinical assessment, clinical trial, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/31549
Clinical Infectious Diseases
LibKey Link

المؤلفون: Russell E.G., Lin S., Lambert J.R., Nicholson L., Dakic B., Midolo P.D.

مصطلحات الفهرس: amoxicillin/dt [Drug Therapy], immunoglobulin G/ec [Endogenous Compound], metronidazole/cb [Drug Combination], metronidazole/dt [Drug Therapy], omeprazole/cb [Drug Combination], omeprazole/dt [Drug Therapy], urea/ec [Endogenous Compound], gastrointestinal infection/et [Etiology], analytical equipment, antibiotic therapy, antibody titer, article, breath analysis, clinical article, diagnostic value, enzyme immunoassay, eradication therapy, gastrointestinal infection/di [Diagnosis], gastrointestinal infection/dt [Drug Therapy], Helicobacter pylori, human, intermethod comparison, latex agglutination test, priority journal, treatment outcome, amoxicillin/cb [Drug Combination], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32922
Journal of Gastroenterology and Hepatology
Click here for full text options
LibKey Link

المؤلفون: Russell E.G., Lin S., Lambert J.R., Nicholson L., Dakic B., Midolo P.D.

مصطلحات الفهرس: amoxicillin/dt [Drug Therapy], immunoglobulin G/ec [Endogenous Compound], metronidazole/cb [Drug Combination], metronidazole/dt [Drug Therapy], omeprazole/cb [Drug Combination], omeprazole/dt [Drug Therapy], urea/ec [Endogenous Compound], gastrointestinal infection/et [Etiology], analytical equipment, antibiotic therapy, antibody titer, article, breath analysis, clinical article, diagnostic value, enzyme immunoassay, eradication therapy, gastrointestinal infection/di [Diagnosis], gastrointestinal infection/dt [Drug Therapy], Helicobacter pylori, human, intermethod comparison, latex agglutination test, priority journal, treatment outcome, amoxicillin/cb [Drug Combination], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32922
Journal of Gastroenterology and Hepatology
LibKey Link